TORONTO, Sept. 1,
2021 /CNW/ - Paula Amy
Hewitt, General Counsel and Chief Privacy Officer, Field
Trip Health Ltd., ("Field Trip" or the "Company")
(TSX: FTRP), shares her Company's story in
an interview with TMX
Group.
The C-Suite at The Open video interview series highlights
the unique perspectives of listed companies on Toronto Stock
Exchange and TSX Venture Exchange. Videos provide insight
into how company executives think in the current business
environment. To see the latest C-Suite at The
Open videos visit
https://www.tmxmoney.com/en/csuite.html
.
About Field Trip Health Ltd., (TSX:
FTRP)
A leader in the development and delivery of psychedelic
therapies, Field Trip is developing next generation psychedelic
molecules and the clinical infrastructure to deliver psychedelics
at scale. Through its Field Trip Discovery division, Field Trip is
advancing clinical work on FT-104, a novel psychedelic molecule,
and through its Field Trip Health division, the company is creating
a global brand of psychedelic-assisted therapy and
ketamine-assisted therapy centres to more effectively address
depression, anxiety addiction and other mental health
conditions. For more information visit:
https://www.meetfieldtrip.com .
SOURCE Toronto Stock Exchange